Skip to content

Effect of Sufentanil on the Postoperative Pain

Analgesic Effect of Intraoperative Sufentanil on Postoperative Pain in Patients Undergoing Robot-assisted Nephrectomy: a Prospective Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06260046
Enrollment
48
Registered
2024-02-15
Start date
2024-03-01
Completion date
2027-01-15
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Acute

Brief summary

This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery.

Interventions

DRUGSufentanil

Induction: sufentanil TCI 0.3 ng/ml Maintenance: sufentanil TCI 0.05-0.5 ng/ml

DRUGRemifentanil

Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who undergo elective robot-assisted nephrectomy surgery * American Society of Anesthesiologists grade 1,2,3 * Age \> 18 years old

Exclusion criteria

* Refuse to participate to the study * Allergic history of opioid * chronic pain * opioid user before surgery * MAO inhibitor user * Severe respiratory insufficiency

Design outcomes

Primary

MeasureTime frame
opioid consumptionDuring post-anesthesia care unit(PACU) stay, until 1 hour

Secondary

MeasureTime frameDescription
Richmond Agitation-Sedation scaleDuring post-anesthesia care unit(PACU) stay, until 1 hour(+4), Combative, Overtly combative or violent; immediate danger to staff (+3), Very agitated, Pulls on or removes tube(s) or catheter(s) or has aggressive behavior toward staff (+2), Agitated, Frequent nonpurposeful movement or patient-ventilator dyssynchrony (+1), Restless, Anxious or apprehensive but movements not aggressive or vigorous 0, Alert and calm, Spontaneously pays attention to caregiver (-1), Drowsy, Not fully alert, but has sustained (more than 10 seconds) awakening, with eye contact, to voice (-2), Light sedation, Briefly (less than 10 seconds) awakens with eye contact to voice (-3), Moderate sedation, Any movement (but no eye contact) to voice (-4), Deep sedation, No response to voice, but any movement to physical stimulation (-5), Unarousable, No response to voice or physical stimulation
Incidence of postoperative nausea and vomitingDuring post-anesthesia care unit(PACU) stay, until 1 hour
Number of patients who administered antiemeticsDuring post-anesthesia care unit(PACU) stay, until 1 hourramosetron will be administered as antiemetics
Pain scoreimmediately after surgery, 15minutes, 30minutes, 60minutes after surgeryNumeric rating scale (0=none, 10=extremely pain)

Countries

South Korea

Contacts

Primary ContactChang-Hoon Koo
vollock9@gmail.com+821085098841

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026